Professor Anil Koul

Vice President and Head of Global Public Health Discovery Research at Johnson & Johnson and Professor of Translational Discovery at the London School of Hygiene and Tropical Medicine

Prof. Anil Koul is currently Vice President and Head of Global Public Health Discovery Research at Johnson & Johnson. He is also Professor of Translational Discovery at The London School of Hygiene and Tropical Medicine. The lab in the London School is focused on TB translational medicine research. He is a member of the Board Of Directors at Janssen Pharmaceutica NV, Belgium and a Scientific Advisory Board Member for the Council of Scientific and Industrial Research (CSIR), government of India. He has played a key role in discovery and development of the new TB drug, named bedaquiline. For the discovery of bedaquiline, he was awarded with several awards, including the American Chemical Society (ACS) Annual Award in 2020.

Top